|
| Home | Article Database | Resources | Tools & Just for Fun | Search HY |
Waardeburg Syndrome
Description
Waardenburg syndrome (WS) is an inherited disorder often characterized by
varying degrees of hearing loss and changes in skin and hair pigmentation. The
syndrome got its name from a Dutch eye doctor named Petrus Johannes
Waardenburg who first noticed that people with differently colored eyes often
had a hearing impairment. He went on to study over a thousand individuals in
deaf families and found that some of them had certain physical characteristics
in common.
One commonly observed characteristic of Waardenburg syndrome is two
differently colored eyes. One eye is usually brown and the other blue.
Sometimes, one eye has two different colors. Other individuals with
Waardenburg syndrome may have unusually brilliant blue eyes.
People with WS may also have distinctive hair coloring, such as a patch of
white hair or premature gray hair as early as age 12. Other possible physical
features include a wide space between the inner corners of eyes called a
broad nasal root. In addition persons with WS may have low frontal hairline
and their eyebrows may connect. The levels of hearing loss associated with the
syndrome can vary from moderate to profound.
Individuals with Waardenburg syndrome may have some or all of the traits of
the syndrome. For example, a person with WS may have a white forelock, a
patch of white hair near the forehead and no hearing impairment. Others may
have white patches of skin and severe hearing impairment. The severity of the
hearing impairment varies among individuals with WS as do changes in the
skin and hair.
On rare occasions, WS has been associated with other conditions that are
present at birth, such as intestinal disorders, elevation of the shoulder blade,
and disorders of the spine. A facial abnormality, known as cleft lip and/or
palate, also has been associated with WS.
Types of WS
There are at least four types of Waardenburg syndrome. The most common
types of WS identified by scientists are Type 1 and Type 2. The different
types of physical characteristics a person has determines the type of WS.
Persons who have an unusually wide space between the inner corners of their
eyes have WS Type 1. Hearing impairments occur in about 20 percent of
individuals with this type of Waardenburg syndrome. Persons who do not
have a wide space between the inner corners of their eyes, but who have
many other WS characteristics are described as having WS Type 2. About 50
percent of persons with WS Type 2 have a hearing impairment or are deaf.
Cause
As a genetic disorder, Waardenburg syndrome is passed down from parent to
child much like hair color, blood type, or other physical traits. A child receives
genetic material from each parent. Because Waardenburg syndrome is a
dominant condition, a child usually inherits the syndrome from just one parent
who has the malfunctioning WS gene. Actually, there is a 50/50 chance that a
child of an individual with WS will also have the syndrome.
Research studies
Scientists have identified and located four different genes for Waardenburg
syndrome: PAX3, MITF, EDNRB, and EDN3. WS type 1 and 3 have been
associated with mutations in the PAX3 gene; WS type 2 with the MITF gene;
and WS type 4 with the EDNRB and EDN3 genes. While scientists are
studying all of these genes, currently, the most information is available on the
PAX3 and MITF genes and their role in Waardenburg syndrome.
The PAX3 gene is located on chromosome 2 and controls some aspects of
the development of the face and inner ear. The MITF gene and is found on
chromosome 3. It also controls the development of the ear and hearing.
Scientists are now studying these genes to better understand how they operate
in controlling the normal growth of the ear and the development of hearing.
This information will help scientists understand why persons with WS
sometimes develop hearing problems.
National Institute on Deafness and Other Communication
Disorders
National Institutes of Health
31 Center Drive, MSC 2320
Bethesda, MD USA 20892-2320
NIH Pub. No. 91-3260
March 1999
|